Clinical Trial Update: Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing febuxostat versus allopurinol or placebo in patients with hyperuricosuria and calcium oxalate kidney stones; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricosuria
• Nephrolithiasis

Drugs mentioned

• Allopurinol (Zyloprim) (allopurinol)
• Febuxostat (Uloric) (febuxostat)

Snippet

Sponsor: Takeda | Conditions: Hyperuricosuria, Kidney Stones | Phase 2 | Status: COMPLETED | Results posted: 2013-02-15